June 17, 2019
Breakthrough T1D Played Critical Role in Key Advances Shared at the 79th Annual ADA Scientific Sessions
June 14, 2019
Sports and Entertainment Stars Converge on Capitol Hill to Advocate for Research Funding and Policies that Support the Type 1 Diabetes Community
June 9, 2019
TrialNet Announces Type 1 Diabetes Prevention Breakthrough
May 29, 2019
Parker Institute for Cancer Immunotherapy, Breakthrough T1D and the Helmsley Charitable Trust Form Cancer and Diabetes Research Initiative
May 17, 2019
Breakthrough T1D Statement on FDA Safety Warning for DIY Systems
May 8, 2019
Charities renew investment in the hunt for alternative to century-old Type 1 diabetes treatment
May 6, 2019
Pushing Early Beta-Cell Proliferation Can Halt Autoimmune Attack in Type 1 Diabetes Model
April 9, 2019
Breakthrough T1D Board Appoints Leading Diabetes Researcher and Advocate Aaron J. Kowalski, Ph.D. as New President & CEO
March 22, 2019
Breakthrough T1D Statement on FDA Complete Response Letter for Zynquista™
March 5, 2019
Breakthrough T1D Statement on Eli Lilly Announcement of a New, Lower Cost Generic Insulin
